RMGS PHARMA & AUDITING SERVICES LTDActive

Company number 14499360Private limited companyIncorporated 2022

Key figures

£65,691+10,245.0%
Net assets 2024/25
+1,078.5%
Average annual growth 2022/23–2024/25
020 k40 k60 k80 k2022/232023/242024/25

Like most small UK companies, RMGS PHARMA & AUDITING SERVICES LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2022/232023/242024/25
Filed accounts2022/23–2024/25
2022/232023/242024/25
Cash at bank and in hand88526,09720,278
Total assets14,38526,09795,758
Total liabilities13,91225,46230,067
Net assets / total equity47363565,691
Average number of employees222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: RMGS PHARMA & AUDITING SERVICES LTD

Company

RMGS PHARMA & AUDITING SERVICES LTD is a private limited company registered with Companies House under company number 14499360. It was incorporated on 22 Nov 2022. Its status is active. The registered office is in Watford (WD24). Its nature of business (SIC 2007) is management consultancy activities other than financial management (70229), technical testing and analysis (71200), other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files small company accounts (filleted). Net assets were £65,691, up 10,245% on the previous year. Cash at bank and in hand was £20,278. Total assets were £95,758 and total liabilities £30,067. The company had an average of 2 employees. Figures are available for 3 financial years (2022/23–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 15 Jun 2027.